Work

Supplementary Table S5 from OvaPrint—A Cell-free DNA Methylation Liquid Biopsy for the Risk Assessment of High-grade Serous Ovarian Cancer

Year: 2023

Type: supplementary-materials

Abstract: Table S5: OvaPrint™ risk scores for all cfDNA samples analyzed. Table summarizes the OvaPrint™ risk classification of all cfDNA samples analyzed. Each row represents a unique subtype and class, which denotes high-grade, low-grade, and borderline cases. Totals are annotated in the final row and final column.

DOI: 10.1158/1078-0432.24825865

Authors: David N. Buckley, Juan Pablo Lewinger, Gerald Gooden, Monique Spillman, Monica Neuman, X. Mona Guo, Ben Yi Tew, Heather Miller, Varun U. Khetan, Lee P. Shulman, Lynda Roman, Bodour Salhia

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4389788847

Cites:

Cited by:

Related to: 10